Clinical-Grade Wearable Market worth $148.7 Billion by 2030 - Exclusive Report by InsightAce Analytic
Retrieved on:
Tuesday, September 27, 2022
Glucose, Hypertension, Ketone, Accelerometer, Technology, US, Apple Inc., Medtronic, Research, Conditional sentence, Asian Academy for Sports and Fitness Professionals, Time, Prevalence, Industry, Omron, Part, Investment, Verily, Pain management, Database activity monitoring, Ventilator, ECG, Abbott Laboratories, Amazon, Asthma, Sport, CAGR, Software, Physical fitness, Responsive neurostimulation device, Nurse Next Door Home Healthcare Services, PAP, Presence sensing device, Mobile device, Partnership, Diabetes, Sleep, Genomics, GE Healthcare, Digital, Masimo, Lingo, Lists of diseases, Abbott, Apple, Cancer, Remote patient monitoring, Diagnosis, Garmin, Awareness, Medical device, Withings, Fitbit
According to company's newest research, the global clinical-grade wearable market is worth US$ 19.55 Bn in 2021 and is predicted to reach US$ 148.76 Bn in 2030, with a promising CAGR of 25.56% between 2022 and 2030.
Key Points:
- According to company's newest research, the global clinical-grade wearable market is worth US$ 19.55 Bn in 2021 and is predicted to reach US$ 148.76 Bn in 2030, with a promising CAGR of 25.56% between 2022 and 2030.
- A wide variety of medical wearable technology is available on the market today.
- Some examples of this technology include smartwatches and fitness-tracking devices, wearable ECG and blood pressure monitors, biosensors, and others.
- In the Clinical-Grade Wearable Market, however, there is a lack of norms and regulations, accuracy, standardisation, and analysis of wearable-generated data.